共 50 条
- [32] Type-2-Diabetes - Aliskiren promises high nephroprotective potential [J]. HERZ, 2007, 32 (08) : A17 - A18
- [33] Ipragliflozin for the Treatment of Fatty Liver Disease in Type-2-Diabetes [J]. DIABETOLOGE, 2022, 18 (01): : 67 - 68
- [34] Type-2-Diabetes Disease Management Guidelines can be commented [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2020, 117 (31-32): : A1518 - A1518
- [35] Early detection of Type-2-Diabetes [J]. DIABETES STOFFWECHSEL UND HERZ, 2019, 28 (03): : 156 - 156
- [36] Neurohumoral stimulation in type-2-diabetes as an emerging disease concept [J]. Cardiovascular Diabetology, 3
- [37] Customized treatment of Type-2-Diabetes [J]. DIABETES STOFFWECHSEL UND HERZ, 2017, 26 (05): : 277 - 278
- [39] Type-2-diabetes in children and adolescents [J]. MONATSSCHRIFT KINDERHEILKUNDE, 2001, 149 (07) : 660 - 669
- [40] Kidney Disease and Increased Mortality Risk in Type 2 Diabetes [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 24 (02): : 302 - 308